Publication | Closed Access

Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid

AntibioticsHiv-related TuberculosisTuberculosisAntimicrobial ChemotherapyAcquired Rifamycin MonoresistanceOnce-weekly RifapentineHivMedicineAntimicrobial ResistanceDrug Resistance